Biological contaminants identified from laryngeal mask airways

Abstract

Ten laryngeal mask airways (LMA), reused between 10 and 40 times, were collected from two UK NHS hospitals. All had been cleaned, autoclaved, inspected and repackaged using routine procedures recommended by the manufacturer, and were ready for reuse. These devices were collected, unpacked and subject to the biochemical analysis of erythrosine B staining on the outer surface areas of samples cut from the middle of the tube, the front middle and tip of the cuff. Parallel physical analysis using infrared (IR) spectroscopy was performed on sample cuts from the same areas as for the staining. Both surface infrared spectroscopy and biochemical assay revealed strong deposition of protein-related biological debris on almost all LMAs, with cuffs being contaminated more intensively than tubes. The results reveal that routine hospital LMA cleaning and sterilisation, coupled with visual inspection, are inadequate for identifying and removing protein related biological debris on reused LMAs. In light of the concern of possible cross-contamination, single-use LMAs should be encouraged.

Keywords

Prion protein blood protein laryngeal mask airways (LMA)hospital infection control

Get full access to this article

View all access options for this article.

References

Brian Aij , Denman WT , Goudsouzian NG (2000) LMA-Classic and LMA-Flexible instruction manual. LMA North America: San Diego.

Blint MC , Burchett KR (2003) Creutzfeldt-Jacob disease and disposable anaesthetic equipment-balancing the risks. British Journal of Anaesthesia 90:1-3.

Brimacombe JR , Brian Aij. (1997) The laryngeal mask airway: a review and practical guide. WB Saunders: London.

Chu L. , Trudell JR , Brock-Utne JG (2002) Autoclaved reusable laryngeal mask airways contain significant protein contamination. Anesthesiology 96: A570.

Department of Health. (1999) Decontamination guidance. CD-ROM from NHS Estates. DH: London.

Department of Health. (2002) Association of Anaesthetists guidelines. Department of Health: London.

Department of Health. (2003) Transmissible spongiform encephalopathy agents: safe working and the prevention of infection — revised guidance. Department of Health : London.

Dong A. , Matsuura J. , Allison SD , Chrisman E. , Manning MC , Carpenter JF (1996) Infrared and circular dichroism spectroscopic characterisation of structural differences between beta-lactoglobulin A and B. Biochemistry 35:1450-7.

Estebe JP (1997) Prion disease and anaesthesia. Ann Fr Anesth 16: 955-63.

10.

Farling P. , Smith G. (2003) Anaesthesia for patients with Creutzfeldt-Jakob disease: a practical guide. Anaesthesia 58: 627-9.

11.

Green RJ , Su TJ , Lu JR , Webster Jrp. (2001) The displacement of preadsorbed protein with a cationic surfactant at the hydrophilic SiO2-water interface. J Phys Chem B 105: 9331-8.

12.

Haltia M. (2000) Human prion diseases. Annal Medicine 32: 493-500.

13.

Hill AF , Butterworth RJ , Joiner S. , Jackson G. , Rossor MN , Thomas DJ , et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183-9.

14.

Johnson P. , Garland PB (1982) Phosphorescent triplet probe for studying rotational diffusion of membrane proteins. Biochem J 203: 313-21.

15.

Kascsak RJ , Rubenstein R. , Merz PA , Tonnademasi M. , Fersko R. , Carp RI , et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688-93.

16.

Kawashima T. , Furukawa H. , Dohura K. , Iwaki T. (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 350: 68-9.

17.

LMA North America webpage. (2003) See: www.LMANA.com. The revised 2001 version of user manual can be found together with instructions for cleaning and decontamination, and device inspection.

18.

LMA North America. (2000) Instruction manual for LMA-Classic™/LMA-Flexible™. LMA North America: San Diego.

19.

Lu JR , Su TJ , Thomas J. (1998) Binding of surfactants onto preadsorbed layers of bovine serum albumin at the silica-water interface. J Phys Chem B 102: 10307-15.

20.

The UK Medical Devices Agency (MDA). (2002 ) Sterilisation, disinfection and cleaning of medical equipment: guidance on decontamination from the UK Microbiology Advisory Committee to Department of Health. Medical Devices Agency: London.

21.

Miller DM , Youkhana I. , Karunaratne WU , Pearce A. (2001) Presence of protein deposits on `cleaned' re-usable anaesthetic equipment. Anaesthesia 56:1069-72.

22.

Parker MR , Day Cje. (2000) Visible and occult blood contamination of laryngeal mask airways and tracheal tubes used in adult anaesthesia. Anaesthesia 55: 367-90.

23.

Shin HJ , Lee EK , Lee JH , D.Lee , C. Chang , Y. Kim , et al. (2000) Eosin interaction of alpha-synuclein leading to protein self-oligomerisation. Biochem Biophys Acta 1481:139-46.

24.

Smith G. (2001) Variant CJD: what you need to know at present. Bulletin of Royal College of Anaesthetists 7: 302-4.

25.

Transmissible Spongiform Encephalopathy Agents (TSEA). (1998) Safe working and the prevention of infection-advisory committee (UK) on dangerous pathogens (ACDP) and the spongiform encephalopathy advisory committee (SEAC). TSEA: London (ISBN 0 11 322166 5).

26.

van Stockham IHM , Linsdell H. , Hadden JM , Haris PI , Chapman D. , Bloemendal M. (1995) Temperature-induced changes in protein structures studied by Fourier transform infrared spectroscopy and global analysis. Biochemistry 34:10508-18.

27.

Variant Creutzfeldt-Jakob Disease (vCJD). ( 1999) Minimising the risk of transmission. Health Service Circular (HSC) 1999/178: UK.

28.

Verghese C. , Brimacombe JR (1996) Survey of laryngeal mask usage in 11910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg 82: 129-33.